News Center
BroadenBio Obtained the "Zhongguancun" High-Tech Enterprise Certification
Time of issue:
2019-07-01
Author:
BroadenBio
Origin:
BroadenBio

On July 1, 2019, after being reviewed by the Zhongguancun Science and Technology Park Management Committee, BroadenBio Co., Ltd. was awarded the "Zhongguancun High-tech Enterprise" certification. This marks the recognition of the R&D strength and innovation ability of BroadenBio.
Founded by senior scientists and managers in the pharmaceutical industry in 2018, BroadenBio has established an enthusiastic and professional team, covers various aspects of the industry chain.
With in-depth knowledge in immunology, BroadenBio is active in exploring the fields of immuno-oncology and autoimmune diseases, through independent research and international collaboration. It is our vision to develop new drugs for the treatment of related diseases, and to let immunotherapy benefit the majority of patients.
previous page
previous page